Q9UBW5 (BIN2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 84.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Bridging integrator 2 Alternative name(s): Breast cancer-associated protein 1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 565 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Promotes cell motility and migration, probably via its interaction with the cell membrane and with podosome proteins that mediate interaction with the cytoskeleton. Modulates membrane curvature and mediates membrane tubulation. Plays a role in podosome formation. Inhibits phagocytosis. Ref.8 |
| Subunit structure | Homodimer. Interacts with BIN1. Interacts with ARHGEF6 (via SH3 domain), ARHGEF7 (via SH3 domain), SH3GL1, SH3GL2 and SH3GL3. Identified in a complex with ARHGEF6 and GIT2. Ref.1 Ref.8 |
| Subcellular location | Cytoplasm. Cell projection › podosome membrane; Peripheral membrane protein; Cytoplasmic side. Cytoplasm › cell cortex. Cell projection › phagocytic cup. Note: Associates with membranes enriched in phosphoinositides. Detected in the actin-rich cell cortex at the leading edge of migrating cells. Detected at podosomes, at an actin-rich ring-like structure. Ref.1 Ref.8 |
| Tissue specificity | Detected in natural killer cells (at protein level). Highest level expression seen in spleen and peripheral blood leukocytes and is also expressed at high levels in thymus, colon and placenta, suggesting preferential expression in hematopoietic tissues. Ref.1 Ref.8 |
| Induction | Up-regulated during monocytic differentiation. Ref.1 |
| Domain | The BAR domain mediates dimerization and interaction with membranes enriched in phosphatidylinositides. Ref.8 |
| Sequence similarities | Contains 1 BAR domain. |
| Sequence caution | The sequence BAA91376.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. The sequence BAA91376.1 differs from that shown. Reason: Frameshift at position 156. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| BIN1 | O00499 | 2 | EBI-2042570,EBI-719094 |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9UBW5-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9UBW5-2) The sequence of this isoform differs from the canonical sequence as follows: 105-136: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 565 | 565 | Bridging integrator 2 | PRO_0000256140 | ||||||||||||||||||||
Regions | ||||||||||||||||||||||||
| Domain | 28 – 244 | 217 | BAR | |||||||||||||||||||||
| Coiled coil | 304 – 329 | 26 | Potential | |||||||||||||||||||||
| Compositional bias | 253 – 256 | 4 | Poly-Ser | |||||||||||||||||||||
| Compositional bias | 413 – 479 | 67 | Pro-rich | |||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||
| Modified residue | 273 | 1 | Phosphoserine Ref.7 | |||||||||||||||||||||
| Modified residue | 357 | 1 | Phosphoserine Ref.7 | |||||||||||||||||||||
| Modified residue | 436 | 1 | Phosphoserine Ref.7 | |||||||||||||||||||||
| Modified residue | 438 | 1 | Phosphothreonine Ref.7 | |||||||||||||||||||||
| Modified residue | 444 | 1 | Phosphoserine Ref.7 | |||||||||||||||||||||
| Modified residue | 447 | 1 | Phosphoserine Ref.7 | |||||||||||||||||||||
| Modified residue | 458 | 1 | Phosphoserine Ref.7 | |||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||
| Alternative sequence | 105 – 136 | 32 | Missing in isoform 2. | VSP_021328 | ||||||||||||||||||||
| Natural variant | 48 | 1 | S → N. Ref.2 Corresponds to variant rs7312857 [ dbSNP | Ensembl ]. | VAR_028883 | ||||||||||||||||||||
| Natural variant | 529 | 1 | N → D. Ref.1 Ref.2 Ref.3 Ref.5 Corresponds to variant rs7954976 [ dbSNP | Ensembl ]. | VAR_028884 | ||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||
| Mutagenesis | 13 | 1 | F → A: Strongly reduces binding to membranes. Ref.8 | |||||||||||||||||||||
| Mutagenesis | 21 | 1 | F → A: Strongly reduces binding to membranes. Ref.8 | |||||||||||||||||||||
| Mutagenesis | 81 | 1 | V → R: Abolishes dimerization and membrane binding; when associated with E-214. Ref.8 | |||||||||||||||||||||
| Mutagenesis | 214 | 1 | S → E: Abolishes dimerization and membrane binding; when associated with R-81. Ref.8 | |||||||||||||||||||||
| Sequence conflict | 163 | 1 | Missing in AAD54227. Ref.1 | |||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||
| Helix | 16 – 31 | 16 | ||||||||||||||||||||||
| Helix | 41 – 88 | 48 | ||||||||||||||||||||||
| Helix | 96 – 120 | 25 | ||||||||||||||||||||||
| Helix | 122 – 130 | 9 | ||||||||||||||||||||||
| Helix | 132 – 160 | 29 | ||||||||||||||||||||||
| Beta strand | 161 – 164 | 4 | ||||||||||||||||||||||
| Helix | 167 – 200 | 34 | ||||||||||||||||||||||
| Helix | 202 – 241 | 40 | ||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Bin2, a functionally nonredundant member of the BAR adaptor gene family." Ge K., Prendergast G.C. Genomics 67:210-220(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT ASP-529, INDUCTION, INTERACTION WITH BIN2, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [2] | "Genomic structure and chromosome location of the BRAP1 gene." Miki Y., Saito H. Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), VARIANTS ASN-48 AND ASP-529. Tissue: Mammary gland. |
| [3] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), VARIANT ASP-529. Tissue: Colon. |
| [4] | "The finished DNA sequence of human chromosome 12." Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R. Gibbs R.A.Nature 440:346-351(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANT ASP-529. Tissue: Ovary. |
| [6] | "Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment." Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J. J. Proteome Res. 7:5167-5176(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: T-cell. |
| [7] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-273; SER-357; SER-436; THR-438; SER-444; SER-447 AND SER-458, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [8] | "Bin2 is a membrane sculpting N-BAR protein that influences leucocyte podosomes, motility and phagocytosis." Sanchez-Barrena M.J., Vallis Y., Clatworthy M.R., Doherty G.J., Veprintsev D.B., Evans P.R., McMahon H.T. PLoS ONE 7:E52401-E52401(2012) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.53 ANGSTROMS) OF 1-238, FUNCTION, DOMAIN, SUBUNIT, INTERACTION WITH ARHGEF6; ARHGEF7; SH3GL1; SH3GL2; SH3GL3, IDENTIFICATION IN A COMPLEX WITH GIT2, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, MUTAGENESIS OF PHE-13; PHE-21; VAL-81 AND SER-214. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF146531 mRNA. Translation: AAD54227.1. AB032698 mRNA. Translation: BAA88108.1. AB032710 Genomic DNA. Translation: BAA88125.1. AK000783 mRNA. Translation: BAA91376.1. Sequence problems. AC046135 Genomic DNA. No translation available. BC047686 mRNA. Translation: AAH47686.1. | ||||||||||||||||||
| IPI | IPI00550792. IPI00795778. | ||||||||||||||||||
| RefSeq | NP_057377.2. NM_016293.2. | ||||||||||||||||||
| UniGene | Hs.14770. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ProteinModelPortal | Q9UBW5. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| IntAct | Q9UBW5. 3 interactions. | ||||||||||||||||||
| STRING | 9606.ENSP00000267012. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | Q9UBW5. | ||||||||||||||||||
Polymorphism databases | |||||||||||||||||||
| DMDM | 143811367. | ||||||||||||||||||
2D gel databases | |||||||||||||||||||
| OGP | Q9UBW5. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PaxDb | Q9UBW5. | ||||||||||||||||||
| PRIDE | Q9UBW5. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENST00000267012; ENSP00000267012; ENSG00000110934. ENST00000452142; ENSP00000410217; ENSG00000110934. | ||||||||||||||||||
| GeneID | 51411. | ||||||||||||||||||
| KEGG | hsa:51411. | ||||||||||||||||||
| UCSC | uc001ryg.3. human. uc009zlz.3. human. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 51411. | ||||||||||||||||||
| GeneCards | GC12M051697. | ||||||||||||||||||
| H-InvDB | HIX0201823. | ||||||||||||||||||
| HGNC | HGNC:1053. BIN2. | ||||||||||||||||||
| HPA | HPA038666. HPA038667. | ||||||||||||||||||
| MIM | 605936. gene. | ||||||||||||||||||
| neXtProt | NX_Q9UBW5. | ||||||||||||||||||
| PharmGKB | PA25356. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| eggNOG | NOG264615. | ||||||||||||||||||
| HOGENOM | HOG000252987. | ||||||||||||||||||
| HOVERGEN | HBG004224. | ||||||||||||||||||
| InParanoid | Q9UBW5. | ||||||||||||||||||
| OMA | RFEQSAS. | ||||||||||||||||||
| OrthoDB | EOG45HRXJ. | ||||||||||||||||||
| PhylomeDB | Q9UBW5. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | Q9UBW5. | ||||||||||||||||||
| Bgee | Q9UBW5. | ||||||||||||||||||
| CleanEx | HS_BIN2. | ||||||||||||||||||
| Genevestigator | Q9UBW5. | ||||||||||||||||||
| GermOnline | ENSG00000110934. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| Gene3D | 1.20.1270.60. 1 hit. | ||||||||||||||||||
| InterPro | IPR027267. AH/BAR-dom. IPR003005. Amphiphysin. IPR004148. BAR_dom. [Graphical view] | ||||||||||||||||||
| Pfam | PF03114. BAR. 1 hit. [Graphical view] | ||||||||||||||||||
| PRINTS | PR01251. AMPHIPHYSIN. | ||||||||||||||||||
| SMART | SM00721. BAR. 1 hit. [Graphical view] | ||||||||||||||||||
| PROSITE | PS51021. BAR. 1 hit. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| ChiTaRS | BIN2. human. | ||||||||||||||||||
| GenomeRNAi | 51411. | ||||||||||||||||||
| NextBio | 54957. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | BIN2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9UBW5 Secondary accession number(s): Q86VV0, Q9NWK4, Q9UKN4 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 12 Human chromosome 12: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
